The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.

The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

Citing concerns about mRNA technology, the Trump administration has pulled funding for a vaccine, even though Moderna says it ...

In a major policy reversal, the U.S. Department of Health and Human Services (HHS) has canceled a $590 million agreement with ...

Since bird flu was first discovered in U.S. cattle last year, the virus has spread to more than 1,000 herds across the ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.

The Trump administration has canceled a contract with the drugmaker Moderna to develop a vaccine for humans to fight off the bird flu, according to CBS News. On Wednesday, the U.S. Health and Human ...

On Wednesday, as news broke that the Trump administration was reneging on the contract, Moderna reported positive results from an early trial of a vaccine targeting H5 influenza viruses. In a ...

Over the past three years, avian influenza (H5N1) has spread around the U.S. and affected many species of birds and mammals, ...

The US has withdrawn $766 million in funding for Moderna's H5N1 vaccine amid a severe bird flu outbreak. This raises concerns ...